Demographic Characteristics of Adults Participating in Clinical Trials of Anti-Amyloid Monoclonal Antibodies to Treat Alzheimer Disease
Publication
, Conference
Zhang, AD; Hastings, SN
Published in: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
April 2020
Duke Scholars
Published In
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
EISSN
1532-5415
ISSN
0002-8614
Publication Date
April 2020
Volume
70
Start / End Page
S13 / S13
Related Subject Headings
- Geriatrics
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhang, A. D., & Hastings, S. N. (2020). Demographic Characteristics of Adults Participating in Clinical Trials of Anti-Amyloid Monoclonal Antibodies to Treat Alzheimer Disease. In JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (Vol. 70, pp. S13–S13).
Zhang, A. D., and S. N. Hastings. “Demographic Characteristics of Adults Participating in Clinical Trials of Anti-Amyloid Monoclonal Antibodies to Treat Alzheimer Disease.” In JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 70:S13–S13, 2020.
Zhang AD, Hastings SN. Demographic Characteristics of Adults Participating in Clinical Trials of Anti-Amyloid Monoclonal Antibodies to Treat Alzheimer Disease. In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2020. p. S13–S13.
Zhang, A. D., and S. N. Hastings. “Demographic Characteristics of Adults Participating in Clinical Trials of Anti-Amyloid Monoclonal Antibodies to Treat Alzheimer Disease.” JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, vol. 70, 2020, pp. S13–S13.
Zhang AD, Hastings SN. Demographic Characteristics of Adults Participating in Clinical Trials of Anti-Amyloid Monoclonal Antibodies to Treat Alzheimer Disease. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2020. p. S13–S13.
Published In
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
EISSN
1532-5415
ISSN
0002-8614
Publication Date
April 2020
Volume
70
Start / End Page
S13 / S13
Related Subject Headings
- Geriatrics
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences